Bright Talks #1: How to balance medical innovation with MDR compliance and cybersecurity

Artificial intelligence is transforming healthcare, supporting clinicians with diagnostics and data interpretation. Yet bringing an innovative medical solution into everyday practice requires far more than advanced technology alone. Success also depends on regulatory compliance, data security, and a responsible approach to product development and market adoption.

In the first episode of Bright Talks, we explored these challenges with Michał Czarnuch, a lawyer and partner at Rymarz Zdort Maruta and a recognised expert in pharmaceutical law, healthcare regulations, and medical device compliance.

Our discussion highlights an important point: regulatory requirements should not be seen as barriers to innovation. On the contrary, robust certification processes help build trust in emerging technologies, enabling their safe and effective adoption across healthcare systems.

Watch the first episode of Bright Talks to discover expert insights into the future of artificial intelligence in healthcare, MDR requirements, and the key challenges shaping the medtech industry.

Why certification should be part of your strategy from day one

Developing a medical device involves far more than creating sophisticated technology. Consider regulatory requirements, data collection methods, and certification planning from the earliest stages of product development.

Many companies focus primarily on product functionality, deferring compliance-related activities until later. In practice, this approach often leads to delays, additional costs, and unexpected obstacles. Companies should systematically collect evidence of a product’s safety and performance throughout the development process, not only as they approach certification.

MDR as a foundation for digital health innovation

The Medical Device Regulation (MDR) has fundamentally changed how medical technologies are developed and commercialised in Europe. Its impact is particularly significant for medical software and AI-driven solutions.

Beyond defining requirements for product quality and safety, the MDR sets expectations for clinical evaluation, risk management, and post-market surveillance. While achieving compliance can be demanding, the objective is clear: ensuring that healthcare providers and patients can rely on medical technologies that meet the highest standards of safety and effectiveness.

Ready-made algorithm is only the beginning

Technological excellence alone does not guarantee a medical product’s success. Companies must also demonstrate that their solution delivers measurable clinical value and performs as intended in real-world healthcare settings.

This typically requires clinical studies, real-world evidence collection and analysis, and comprehensive technical documentation. For many organizations, proving clinical benefit is among the most resource-intensive stages of bringing an innovation to market, yet it is also one of the most important.

Certification is not the finish line

Achieving MDR compliance is a major milestone, but it marks the beginning, not the end, of a product’s journey. The next challenge lies in successful implementation, integration with existing healthcare infrastructure, and adoption by end users.

Healthcare purchasing decisions involve many stakeholders. In addition to physicians, decision-makers often include IT departments, cybersecurity specialists, legal teams, procurement professionals, and hospital administrators. As a result, market adoption requires a deep understanding of the broader healthcare ecosystem and the diverse expectations of its participants.

Cybersecurity as a quality requirement

As healthcare becomes increasingly digital, cybersecurity and data protection have become essential components of medical technology development. Modern solutions must not only comply with legal requirements but also meaningfully protect sensitive health information.

Experts emphasize that effective cybersecurity extends far beyond implementing technical safeguards. It requires clear processes, user awareness and training, ongoing risk management, and a commitment to minimizing the amount of personal data collected and processed.

This is especially relevant for medical imaging platforms and diagnostic software, where strong information security must coexist with rapid, seamless access to patient data for healthcare professionals.

The future of medtech will be build on trust

Artificial intelligence is opening new possibilities across healthcare, from earlier disease detection to more personalized patient care. At the same time, expectations regarding transparency, patient safety, and regulatory compliance continue to grow.

The organizations that will define the future of healthcare innovation are those capable of combining technological advancement with a strong commitment to quality, cybersecurity, and regulatory excellence. In the long term, success will belong not only to the most innovative solutions, but to those that earn the trust of clinicians, patients, healthcare institutions, and regulators alike.